Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.
Berry-Kravis E, Des Portes V, Hagerman R, Jacquemont S, Charles P, Visootsak J, Brinkman M, Rerat K, Koumaras B, Zhu L, Barth GM, Jaecklin T, Apostol G, von Raison F.
Berry-Kravis E, et al. Among authors: rerat k.
Sci Transl Med. 2016 Jan 13;8(321):321ra5. doi: 10.1126/scitranslmed.aab4109.
Sci Transl Med. 2016.
PMID: 26764156
Clinical Trial.